Málaga, Ignacio
Avila, Adrian
Primeaux, Sharon
Kallem, Raja Reddy
Roe, Charles R.
Putnam, William C.
Park, Jason Y.
Shinnar, Shlomo
Ahn, Chul
Pascual, Juan M.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D)
https://doi.org/10.1038/s41598-023-30578-z
Funding for this research was provided by:
Fundación Alicia Koplowitz
National Institute of Neurological Disorders and Stroke (NS094257, NS094257, NS094257, NS094257, NS094257, NS094257)
Glut1 Deficiency Foundation
Article History
Received: 5 January 2023
Accepted: 27 February 2023
First Online: 1 March 2023
Competing interests
: The authors declare no competing interests.